title: Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
abstract: BACKGROUND
  Somatic mutations in the Janus kinase 2 gene (JAK2) occur in many myeloproliferative neoplasms, but the molecular pathogenesis of myeloproliferative neoplasms with nonmutated JAK2 is obscure, and the diagnosis of these neoplasms remains a challenge.
  
  
  METHODS
  We performed exome sequencing of samples obtained from 151 patients with myeloproliferative neoplasms. The mutation status of the gene encoding calreticulin (CALR) was assessed in an additional 1345 hematologic cancers, 1517 other cancers, and 550 controls. We established phylogenetic trees using hematopoietic colonies. We assessed calreticulin subcellular localization using immunofluorescence and flow cytometry.
  
  
  RESULTS
  Exome sequencing identified 1498 mutations in 151 patients, with medians of 6.5, 6.5, and 13.0 mutations per patient in samples of polycythemia vera, essential thrombocythemia, and myelofibrosis, respectively. Somatic CALR mutations were found in 70 to 84% of samples of myeloproliferative neoplasms with nonmutated JAK2, in 8% of myelodysplasia samples, in occasional samples of other myeloid cancers, and in none of the other cancers. A total of 148 CALR mutations were identified with 19 distinct variants. Mutations were located in exon 9 and generated a +1 base-pair frameshift, which would result in a mutant protein with a novel C-terminal. Mutant calreticulin was observed in the endoplasmic reticulum without increased cell-surface or Golgi accumulation. Patients with myeloproliferative neoplasms carrying CALR mutations presented with higher platelet counts and lower hemoglobin levels than patients with mutated JAK2. Mutation of CALR was detected in hematopoietic stem and progenitor cells. Clonal analyses showed CALR mutations in the earliest phylogenetic node, a finding consistent with its role as an initiating mutation in some patients.
  
  
  CONCLUSIONS
  Somatic mutations in the endoplasmic reticulum chaperone CALR were found in a majority of patients with myeloproliferative neoplasms with nonmutated JAK2. (Funded by the Kay Kendall Leukaemia Fund and others.).
authors: J
authors: J
authors: Nangalia
authors: C E
authors: CE
authors: Massie
authors: E J
authors: EJ
authors: Baxter
authors: F L
authors: FL
authors: Nice
authors: G
authors: G
authors: Gundem
authors: D C
authors: DC
authors: Wedge
authors: E
authors: E
authors: Avezov
authors: J
authors: J
authors: Li
authors: K
authors: K
authors: Kollmann
authors: D G
authors: DG
authors: Kent
authors: A
authors: A
authors: Aziz
authors: A L
authors: AL
authors: Godfrey
authors: J
authors: J
authors: Hinton
authors: I
authors: I
authors: Martincorena
authors: P
authors: P
authors: Van Loo
authors: A V
authors: AV
authors: Jones
authors: P
authors: P
authors: Guglielmelli
authors: P
authors: P
authors: Tarpey
authors: H P
authors: HP
authors: Harding
authors: J D
authors: JD
authors: Fitzpatrick
authors: C T
authors: CT
authors: Goudie
authors: C A
authors: CA
authors: Ortmann
authors: S J
authors: SJ
authors: Loughran
authors: K
authors: K
authors: Raine
authors: D R
authors: DR
authors: Jones
authors: A P
authors: AP
authors: Butler
authors: J W
authors: JW
authors: Teague
authors: S
authors: S
authors: O'Meara
authors: S
authors: S
authors: McLaren
authors: M
authors: M
authors: Bianchi
authors: Y
authors: Y
authors: Silber
authors: D
authors: D
authors: Dimitropoulou
authors: D
authors: D
authors: Bloxham
authors: L
authors: L
authors: Mudie
authors: M
authors: M
authors: Maddison
authors: B
authors: B
authors: Robinson
authors: C
authors: C
authors: Keohane
authors: C
authors: C
authors: Maclean
authors: K
authors: K
authors: Hill
authors: K
authors: K
authors: Orchard
authors: S
authors: S
authors: Tauro
authors: M-Q
authors: MQ
authors: Du
authors: M
authors: M
authors: Greaves
authors: D
authors: D
authors: Bowen
authors: B J P
authors: BJP
authors: Huntly
authors: C N
authors: CN
authors: Harrison
authors: N C P
authors: NCP
authors: Cross
authors: D
authors: D
authors: Ron
authors: A M
authors: AM
authors: Vannucchi
authors: E
authors: E
authors: Papaemmanuil
authors: P J
authors: PJ
authors: Campbell
authors: A R
authors: AR
authors: Green
mesh_terms: D000595:Amino Acid Sequence; D001855:Bone Marrow Diseases / Q000235:genetics; D037282:Calreticulin / Q000032:analysis / Q000235:genetics*; D005091:Exons; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D007951:Leukemia, Myeloid / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics; D016133:Polymerase Chain Reaction; D055728:Primary Myelofibrosis / Q000235:genetics*; D017422:Sequence Analysis, DNA; D013920:Thrombocythemia, Essential / Q000235:genetics*
chemical_list: D037282:Calreticulin; C507924:JAK2 protein, human; D053614:Janus Kinase 2